Lactobacillus crispatus DSM25988 as novel bioactive agent to co-aggregate Streptococcus pyogenes and to exclude it by binding to human cells.
- 2022-02-28
- Beneficial Microbes 13(1)
- A. Reiprich
- L. Skalden
- A. Raab
- N. Bolotina
- C. Lang
- PubMed: 35144524
- DOI: 10.3920/BM2021.0103
- Low evidence
*L. crispatus* DSM25988 also inhibits invasion of cultured human epithelial pharyngeal cells by *S. pyogenes.*
- Effect
- Beneficial
- Effect size
- Moderate